Advisors Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Advisors Asset Management's ASND Position: Q3 2026 in Review
Advisors Asset Management increased its Ascendis Pharma (ASND) stake by 2.3% in Q3 2026, buying an estimated $52.2K and bringing the position to 9,352 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #608.
Advisors Asset Management first reported a position in ASND in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.79M in Q1 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Advisors Asset Management held 9,352 shares of Ascendis Pharma worth $2.13M as of Q3 2026.
- Advisors Asset Management bought 206 Ascendis Pharma shares in Q3 2026, an estimated $52.2K.
- Ascendis Pharma made up 0.03% of Advisors Asset Management's portfolio in Q3 2026, its #608 holding.
- Advisors Asset Management first reported a position in Ascendis Pharma in Q1 2020 and has held it in 25 quarters since.
- Advisors Asset Management's Ascendis Pharma position peaked at $2.79M in Q1 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Advisors Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.